Transce3nd, LLC

SEC CIK: 0002023570
Latest filing: Jul 24, 2026

SEC filings (opens in a new tab)

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Transce3nd, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overview All 13F holders of CRSP Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2024

Holdings of CRSP by Transce3nd, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−2−100.0%	Sold out	Holders
Q2 2025	2	$97	<0.1%	00.0%	Unchanged	Holders
Q1 2025	2	$68	<0.1%	00.0%	Unchanged	Holders
Q4 2024	2	$79	<0.1%	–	No prior filing	Holders